Results for tag: "Ischemic Heart Disease Drug"

Ischemic Heart Disease (IHD) is a type of cardiovascular disease caused by a lack of blood flow to the heart. It is the leading cause of death in the United States and other developed countries. Treatment for IHD typically involves lifestyle changes, such as quitting smoking and exercising regularly, as well as medications to reduce the risk of further damage to the heart. The Ischemic Heart Disease Drug market is a subset of the larger Cardiovascular Drugs market. It includes medications that are used to treat IHD, such as antiplatelet drugs, anticoagulants, and cholesterol-lowering drugs. These drugs are used to reduce the risk of heart attack, stroke, and other complications of IHD. Some of the major companies in the Ischemic Heart Disease Drug market include Pfizer, Merck, AstraZeneca, Sanofi, and Novartis. These companies produce a variety of medications to treat IHD, including statins, ACE inhibitors, and beta blockers. Show Less Read more